Searched for
CIPLA BLOCK DEAL
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...- Cipla shares in focus as promoters Samina and Rumana Hamied offload 1.72% stake for Rs 2,111 croreCipla shares are in focus today after Samina Hamied and Rumana Hamied, promoters of the pharmaceutical company, exited by selling their 1.7...
- Promoters Samina and Rumana Hamied exit Cipla; sell 1.72 pc stake for Rs 2,111 croreSamina Hamied and Rumana Hamied, promoters of drug major Cipla, on Monday exited the pharmaceutical company by selling their 1.72 per cent ...
- Cipla shares in focus on Rs 2,000 crore likely block dealCipla's shares are likely to attract attention on Monday as the company's promoters may sell up to a 1.72% stake through block deals. The o...
- Stocks in news: Greaves Cotton, Biocon, Tata Motors, Hyundai, CiplaMarkets advanced nearly 1% last week, recording a two-week rally. Focus today includes Greaves Cotton's IPO plan for its subsidiary, Biocon...
- Cipla promoters to sell 1.72% stake in likely block deal worth Rs 2,000 crore: ReportCipla promoters are likely to sell up to 1.72% stake via a block deal at Rs 1,442 per share, a 6% discount to the current price. This follo...
- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Stocks in news: Paytm, Indus Towers, Vedanta, Cipla, Gland PharmaDomestic markets start positively with Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma in focus. ZEE appoints acting CFO. Tata Technologi...
- Cipla promoters sell 2.53% stake for Rs 2,751 crore"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...
- Cipla promoters sell 2.53% stake for around Rs 2,600 crorePromoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquid...
- Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...
- Promoter entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore: ReportPromoters of drugmaker Cipla are expected to offload 2.53% of their stake in a block deal worth Rs 2637 crore on Wednesday, according to so...
- Promoter group entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore via block deals: ReportThe price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.
- Stocks in news: Angel One, CDSL, Apollo Pipes, Cipla, Aster DM HealthcareEquity indices declined on Tuesday. Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare among top stocks to track today.
- Cipla tanks 5% as promoters sell stake in block dealDr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...
- Cipla promoters to sell 2.5%Yusuf Hamied and Mustafa Hamied, promoters of Cipla, are selling as much as a 2.5% stake in the drugmaker through a block deal on Tuesday t...
- Ten stocks in focus in Thursday morning tradeIndian markets are expected to trade higher. Here is a list of ten stocks which are likely to be in focus today.
- India Inc's 9-mth M&A deal tally at $24 bn: Grant ThorntonIndian M&A market showed moderate levels of deal activity in the first nine months of this year with 377 deals amounting to $23.9 billion.
- AIDS drug Tenofovir price set to crashBlockbuster AIDS drug Tenofovir is set to get cheaper after its inventor and US patent holder Gilead struck non-exclusive licensing deals w...
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
Load More
